(In the Media) ’The role of Japan Agency for Medical Research and Development (AMED) in developing new medicine –The role of HGPI and expectations for medical researchers－’
date : 1/31/2015
Dr. Kiyoshi Kurokawa, HGPI Chairman, and
Dr. Toshio Miyata, HGPI Executive Director, co-authored an opinion piece
in Iyaku (Medicine and Drug) Journal on January 31, 2015.
Top Research & Recommendations Posts
- [Research Report] The Public Opinion Survey on Cancer Genomics and Precision Medicine (March 9, 2022)
- [Recommendations] Proposal on a Global Procurement System for Coronavirus Disease 2019 (COVID-19) Vaccines (September 7, 2020)
- [Policy Recommendations] Furthering the Development of Precision Cancer Medicine —Proposals for Effective Policy Changes Based on Key Characteristics of Precision Medicine in Cancer Treatment— (September 20, 2022)
- [Announcement] HGPI Planetary Health Policy Team Signs Healthy Climate Prescription (August 31, 2022)
- [Joint Report and Recommendations] “Rebalancing Health System: Innovation and Sustainability” A Joint Global Expert Meeting convened by the CSIS and HGPI
